What does CUSIP 02043Q107 represent in this 13F holders report?

CUSIP 02043Q107 is the security identifier for ALNY - ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held ALNY - ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK in Q1 2014?

193 institutional investors reported ALNY - ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK for Q1 2014. Use the holders table for investor-level position and value details.

ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY)

CUSIP: 02043Q107

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class: Equity / COMMON STOCK
Shares outstanding: 133,095,681
Total 13F shares: 55,704,223
Share change: +88,448
Total reported value: $3,739,161,613
Put/Call ratio: 215%
Price per share: $67.14
Number of holders: 193
Value change: +$8,742,143
Number of buys: 110
Number of sells: 77

Quarterly Holders Quick Answers

What is CUSIP 02043Q107?
CUSIP 02043Q107 identifies ALNY - ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2014
Previous quarter: Q4 2013

Recent filing periods for CUSIP 02043Q107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ALNY - ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	7.1%	9,512,811	$611,959,000	—	31 Dec 2013	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	6.1%	8,147,876	$524,153,000	—	31 Dec 2013	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	2.9%	3,814,045	$245,358,000	—	31 Dec 2013	13F
VANGUARD GROUP INC	13F	Company	2.2%	2,967,253	$190,883,000	—	31 Dec 2013	13F
BlackRock Fund Advisors	13F	Company	1.7%	2,213,522	$142,329,000	—	31 Dec 2013	13F
FRANKLIN RESOURCES INC	13F	Company	1.6%	2,144,110	$137,930,000	—	31 Dec 2013	13F
COLUMBIA WANGER ASSET MANAGEMENT LLC	13F	Company	1.4%	1,910,000	$122,870,000	—	31 Dec 2013	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	1.4%	1,899,152	$122,115,000	—	31 Dec 2013	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	1.2%	1,586,502	$102,060,000	—	31 Dec 2013	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	1.1%	1,489,038	$95,745,000	—	31 Dec 2013	13F
STATE STREET CORP	13F	Company	1.1%	1,415,406	$91,049,000	—	31 Dec 2013	13F
Capital World Investors	13F	Company	0.79%	1,054,700	$67,849,000	—	31 Dec 2013	13F
JENNISON ASSOCIATES LLC	13F	Company	0.76%	1,018,156	$65,498,000	—	31 Dec 2013	13F
Alpha Wave Global, LP	13F	Company	0.75%	1,000,000	$64,300,000	—	31 Dec 2013	13F
Slate Path Capital LP	13F	Company	0.75%	1,000,000	$64,300,000	—	31 Dec 2013	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.75%	997,534	$64,141,000	—	31 Dec 2013	13F
BAILLIE GIFFORD & CO	13F	Company	0.67%	893,100	$57,453,000	—	31 Dec 2013	13F
NORTHERN TRUST CORP	13F	Company	0.62%	820,785	$52,776,000	—	31 Dec 2013	13F
MORGAN STANLEY	13F	Company	0.56%	741,563	$47,682,000	—	31 Dec 2013	13F
COLUMBUS CIRCLE INVESTORS	13F	Company	0.49%	658,309	$42,329,000	—	31 Dec 2013	13F
TimesSquare Capital Management, LLC	13F	Company	0.45%	602,900	$38,766,000	—	31 Dec 2013	13F
BB BIOTECH AG	13F	Company	0.35%	471,288	$30,304,000	—	31 Dec 2013	13F
Artisan Partners Limited Partnership	13F	Company	0.33%	443,722	$28,545,000	—	31 Dec 2013	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.33%	440,750	$28,340,000	—	31 Dec 2013	13F
BRIDGER MANAGEMENT, LLC	13F	Company	0.33%	440,000	$28,292,000	—	31 Dec 2013	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	0.27%	354,672	$26,353,000	—	31 Dec 2013	13F
NORGES BANK	13F	Company	0.3%	393,891	$25,339,000	—	31 Dec 2013	13F
Bank of New York Mellon Corp	13F	Company	0.25%	335,204	$21,554,000	—	31 Dec 2013	13F
LORD, ABBETT & CO. LLC	13F	Company	0.24%	319,562	$20,557,000	—	31 Dec 2013	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.24%	316,698	$20,372,000	—	31 Dec 2013	13F
EMERALD ADVISERS, LLC	13F	Company	0.23%	311,466	$20,027,000	—	31 Dec 2013	13F
JPMORGAN CHASE & CO	13F	Company	0.22%	286,482	$18,421,000	—	31 Dec 2013	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.21%	284,605	$18,308,000	—	31 Dec 2013	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.19%	255,604	$16,443,000	—	31 Dec 2013	13F
Cormorant Asset Management, LP	13F	Company	0.19%	250,000	$16,075,000	—	31 Dec 2013	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.17%	221,451	$14,246,000	—	31 Dec 2013	13F
OppenheimerFunds, Inc.	13F	Company	0.14%	182,280	$11,726,000	—	31 Dec 2013	13F
BlackRock Investment Management, LLC	13F	Company	0.12%	161,790	$10,403,000	—	31 Dec 2013	13F
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY	13F	Company	0.12%	156,960	$10,092,000	—	31 Dec 2013	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.12%	155,157	$9,981,000	—	31 Dec 2013	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.11%	142,535	$9,170,000	—	31 Dec 2013	13F
Nationwide Fund Advisors	13F	Company	0.1%	133,450	$8,585,000	—	31 Dec 2013	13F
ArrowMark Colorado Holdings LLC	13F	Company	0.1%	131,979	$8,486,000	—	31 Dec 2013	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.1%	128,692	$8,279,000	—	31 Dec 2013	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.09%	126,426	$8,133,000	—	31 Dec 2013	13F
Artal Group S.A.	13F	Company	0.09%	125,000	$8,038,000	—	31 Dec 2013	13F
FIC CAPITAL INC	13F	Company	0.09%	124,558	$8,009,000	—	31 Dec 2013	13F
CREDIT SUISSE AG/	13F	Company	0.09%	122,011	$7,845,000	—	31 Dec 2013	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.09%	121,376	$7,808,000	—	31 Dec 2013	13F
DEUTSCHE BANK AG\	13F	Company	0.09%	113,756	$7,313,000	—	31 Dec 2013	13F

Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q1 2014

As of 31 Mar 2014, ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) was held by 193 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 55,704,223 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT CO LLP, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, BlackRock Fund Advisors, GILDER GAGNON HOWE & CO LLC, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, BlackRock Institutional Trust Company, N.A., and State Street Corp. This page lists 193 institutional shareholders reporting positions in this security for the Q1 2014 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2014 vs Q4 2013 Across Filers

Q4 2013 holders

165

Q1 2014 holders

193

Holder diff

Investor	Q4 2013 Shares	Q1 2014 Shares	Share Diff	Share Chg %	Q4 2013 Value $	Q1 2014 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.